Estrogen Signalling in the Pathogenesis of Age-Related Macular Degeneration

References

• Kaarniranta K, Sinha D, Blasiak J, Kauppinen A, Vereb Z, Salminen A, et al. Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 2013;9:973–984
   PubMed Web of Science ®Google Scholar
• Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1991;32:8–20
   PubMed Web of Science ®Google Scholar
• Eisner A, Klein ML, Zilis JD, Watkins MD. Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1992;33:3091–3102
   PubMed Web of Science ®Google Scholar
• Owsley C, McGwin G Jr, Jackson GR, Kallies K, Clark M. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology 2007;114:1728–1735
   PubMed Web of Science ®Google Scholar
• Dimitrov PN, Robman LD, Varsamidis M, Aung KZ, Makeyeva G, Busija L, et al. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012;53:5213–5220
   PubMed Web of Science ®Google Scholar
• Vision 2020. Right to sight. Blindness and visual impairment: Global facts. Available from www.iapb.org\vision-2020\global-facts, 2014
   Google Scholar
• Gordois A, Cutler H, Pezzullo L, Gordon K, Cruess A, Winyard S, et al. An estimation of the worldwide economic and health burden of visual impairment. Glob Public Health 2012;7:465–481
   PubMed Web of Science ®Google Scholar
• Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med 2012;33:295–317
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. Seven new loci associated with age-related macular degeneration. Nat Genet 2013;45:433–439
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 2010;13;10:31
   Google Scholar
• Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227–253
   PubMed Web of Science ®Google Scholar
• Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 2002;109:1092–1097
   PubMed Web of Science ®Google Scholar
• Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts and fish intake. Arch Ophthalmol 2003;121:1728–1737
   PubMed Web of Science ®Google Scholar
• Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209–218
   PubMed Web of Science ®Google Scholar
• Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 2006;124:995–1001
   PubMed Web of Science ®Google Scholar
• Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001;119:1191–1199
   PubMed Web of Science ®Google Scholar
• SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007;125:671–679
   PubMed Web of Science ®Google Scholar
• Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012;119:571–580
   PubMed Web of Science ®Google Scholar
• Ying GS, Maguire MG, Alexander J, Martin RW, Antoszyk AN; Complications of Age-related Macular Degeneration Prevention Trial Research Group. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial. Arch Ophthalmol 2009;127:1147–1151
   PubMedGoogle Scholar
• Klein BE, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994;92:289–295
   PubMedGoogle Scholar
• Cui J, Shen Y, Li R. Estrogen synthesis and signalling pathways during aging: from periphery to brain. Trends Mol Med 2013;19:197–209
   PubMed Web of Science ®Google Scholar
• Chang JR, Koo E, Agron E, Hallak J, Clemons T, Azar D, et al. Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. Ophthalmology 2011;118:2113–2119
   PubMed Web of Science ®Google Scholar
• Wong TY. Age-related macular degeneration: why should stroke physicians care? Stroke 2010;41:575–576
   Google Scholar
• Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 2009;40:1032–1037
   PubMed Web of Science ®Google Scholar
• Hu CC, Ho JD, Lin HC. Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study. Stroke. 2010;41:613–617
   PubMed Web of Science ®Google Scholar
• Khosla S, Atkinson EJ, Melton LJ, 3rd Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997;82:1522–1527
   PubMed Web of Science ®Google Scholar
• Seitzman RL, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, et al.; Study of Osteoporotic Fractures Research Group. Bone mineral density and age-related maculopathy in older women. J Am Geriatr Soc 2007;55:740–746
   Google Scholar
• Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 2006;27:299–402
   PubMedGoogle Scholar
• Marin-Castano ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50–59
   PubMed Web of Science ®Google Scholar
• Nishihara E, Nagayama Y, Inoue S, Hiroi H, Muramatsu M, Yamashita S, et al. Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology 2000;141:615–620
   PubMedGoogle Scholar
• Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906–1911
   PubMed Web of Science ®Google Scholar
• Munaut C, Lambert V, Noel A, Frankenne F, Deprez M, Foidart JM, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol 2001;85:877–882
   PubMed Web of Science ®Google Scholar
• Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 2000;141:3403–3411
   PubMed Web of Science ®Google Scholar
• Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003;206:13–22
   PubMed Web of Science ®Google Scholar
• Vegeto E, Ciana P, Maggi A. Estrogen and inflammation: hormone generous action spreads to the brain. Mol Psychiatry 2002;7:236–238
   Google Scholar
• Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005;146:624–632
   PubMed Web of Science ®Google Scholar
• Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008;126:519–524
   PubMedGoogle Scholar
• Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006;141:79–87
   PubMed Web of Science ®Google Scholar
• Freeman EE, Munoz B, Bressler SB, West SK. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: the Salisbury Eye Evaluation Project. Ophthalmic Epidemiol 2005;12:37–45
   PubMed Web of Science ®Google Scholar
• Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C; Pola Study Group. Sex steroids and age-related macular degeneration in older French women: the POLA study. Ann Epidemiol 2004;14:202–208
   PubMed Web of Science ®Google Scholar
• Klein BE, Howard KP, Lee KE, Iyengar SK, Sivakumaran TA, Klein R. The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2012;119:1628–1633
   PubMed Web of Science ®Google Scholar
• Wang JJ, Fong CS, Rochtchina E, Cugati S, de Loryn T, Kaushik S, et al. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons. Ophthalmology 2012;119:2298–2303
   PubMed Web of Science ®Google Scholar
• Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: a case-control study. BMJ 1995;310:1570–1571
   PubMed Web of Science ®Google Scholar
• Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997;25:S13–S15
   PubMedGoogle Scholar
• Snow KK, Cote J, Yang W, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related maculopathy in post-menopausal women. Am J Ophthalmol 2002;134:842–848
   PubMed Web of Science ®Google Scholar
• Boekhoorn SS, Vingerling JR, Uitterlinden AG, Van Meurs JB, van Duijn CM, Pols HA, et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci 2007;48:1012–1017
   PubMedGoogle Scholar
• Vinding T, Nielsen NV. Retinopathy caused by treatment with tamoxifen in low dosage. Acta Ophthalmol (Copenh) 1983;61:45–50
   Google Scholar
• Eisner A, Luoh CW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res 2011;36:867–885
   PubMed Web of Science ®Google Scholar
• Tamer C, Oksuz H, Sogut S. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration. Am J Ophthalmol 2007;143:212–216
   Google Scholar
• Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, Hernandez EP, Elliot S, Cousins SW. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 2005;80:413–423
   PubMed Web of Science ®Google Scholar
• Moeinpour F, Choudhry MA, Kawasaki T, Timares L, Schwacha MG, Bland KI, et al. 17 Beta-estradiol normalizes Toll receptor 4, mitogen activated protein kinases and inflammatory response in epidermal keratinocytes following trauma-hemorrhage. Mol Immunol 2007;44:3317–3323
   Google Scholar
• Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90–119
   PubMed Web of Science ®Google Scholar
• Tani A, Yasui T, Matsui S, Kato T, Kunimi K, Tsuchiya N, et al. Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition. Cytokine 2013;62:86–90
   PubMed Web of Science ®Google Scholar
• Zhao R. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective. Int J Med Sci 2012;9:825–832
   Google Scholar
• Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 2003;177:423–433
   PubMed Web of Science ®Google Scholar
• Koka S, Petro TM, Reinhardt RA. Estrogen inhibits interleukin-1beta-induced interleukin-6 production by human osteoblast-like cells. J Interferon Cytokine Res 1998;18:479–483
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Santagati S, Sautebin L, Mazzon E, Calabro G, Serraino I, et al. 17 beta-Estradiol anti-inflammatory activity in carrageenan-induced pleurisy. Endocrinology 2000;141:1455–1463
   PubMed Web of Science ®Google Scholar
• Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115–134
   PubMed Web of Science ®Google Scholar
• Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci 2005;360:2335–2345
   PubMed Web of Science ®Google Scholar
• Schutt F, Davies S, Kopitz J, Holz FG, Boulton ME. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 2000;41:2303–2308
   PubMed Web of Science ®Google Scholar
• Schutt F, Bergmann M, Holz FG, Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:3663–3668
   PubMed Web of Science ®Google Scholar
• Kaarniranta K, Ryhanen T, Karjalainen HM, Lammi MJ, Suuronen T, Huhtala A, et al. Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells. Neurosci Lett 2005;382:185–190
   Google Scholar
• Kaemmerer E, Schutt F, Krohne TU, Holz FG, Kopitz J. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci 2007;48:1342–1347
   PubMed Web of Science ®Google Scholar
• Vives-Bauza C, Anand M, Shirazi AK, Magrane J, Gao J, Vollmer-Snarr HR, et al. The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J Biol Chem 2008;283:24770–24780
   PubMed Web of Science ®Google Scholar
• Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol 2009;54:96–117
   PubMed Web of Science ®Google Scholar
• Lei L, Tzekov R, McDowell JH, Smith WC, Tang S, Kaushal S. Formation of lipofuscin-like material in the RPE Cell by different components of rod outer segments. Exp Eye Res 2013;112:57–67
   Google Scholar
• Kauppinen A, Niskanen H, Suuronen T, Kinnunen K, Salminen A, Kaarniranta K. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-Implications for age-related macular degeneration (AMD). Immunol Lett 2012;147:29–33
   PubMed Web of Science ®Google Scholar
• Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012;149:847–859
   PubMed Web of Science ®Google Scholar
• Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003;34:546–552
   PubMed Web of Science ®Google Scholar
• Moor AN, Gottipati S, Mallet RT, Sun J, Giblin FJ, Roque R, et al. A putative mitochondrial mechanism for antioxidative cytoprotection by 17beta-estradiol. Exp Eye Res 2004;78:933–944
   PubMedGoogle Scholar
• Vina J, Sastre J, Pallardo FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res 2006;40:1359–1365
   PubMed Web of Science ®Google Scholar
• Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, et al. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 2005;4:113–118
   PubMed Web of Science ®Google Scholar
• Nixon E, Simpkins JW. Neuroprotective effects of non-feminizing estrogens in retinal photoreceptor neurons. Invest Ophthalmol Vis Sci 2012;53:4739–4747
   Google Scholar
• Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 1998;84:7–10
   PubMed Web of Science ®Google Scholar
• Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995;15:4971–4979
   PubMed Web of Science ®Google Scholar
• Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997;409:79–85
   PubMed Web of Science ®Google Scholar
• Galien R, Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res 1997;25:2424–2429
   PubMed Web of Science ®Google Scholar
• Paimela T, Ryhanen T, Mannermaa E, Ojala J, Kalesnykas G, Salminen A, et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol Lett 2007;110:139–144
   Web of Science ®Google Scholar
• Sun WH, Keller ET, Stebler BS, Ershler WB. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 1998;244:691–695
   PubMedGoogle Scholar
• Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74:311–317
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997;277:1508–1510
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000;14:1649–1660
   PubMed Web of Science ®Google Scholar
• Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 2008;47:409–414
   PubMed Web of Science ®Google Scholar
• Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999;19:2455–2463
   PubMed Web of Science ®Google Scholar
• Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000;141:3646–3656
   PubMed Web of Science ®Google Scholar
• Reed JL, Dimayuga FO, Davies LM, Keller JN, Bruce-Keller AJ. Estrogen increases proteasome activity in murine microglial cells. Neurosci Lett 2004;367:60–65
   Google Scholar
• Li Y, Wang YS, Shen XF, Hui YN, Han J, Zhao W, et al. Alterations of activity and intracellular distribution of the 20S proteasome in ageing retinal pigment epithelial cells. Exp Gerontol 2008;43:1114–1122
   Google Scholar
• Ryhanen T, Hyttinen JM, Kopitz J, Rilla K, Kuusisto E, Mannermaa E, et al. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J Cell Mol Med 2009;13:3616–3631
   PubMed Web of Science ®Google Scholar
• Viiri J, Hyttinen JM, Ryhanen T, Rilla K, Paimela T, Kuusisto E, et al. P62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol Vis 2010;16:1399–1414
   Google Scholar
• Viiri J, Amadio M, Marchesi N, Hyttinen JM, Kivinen N, Sironen R, et al. Autophagy activation clears ELAVL1/HuR-mediated accumulation of SQSTM1/p62 during proteasomal inhibition in human retinal pigment epithelial cells. PLoS One 2013;8:e69563
   PubMed Web of Science ®Google Scholar
• Giddabasappa A, Bauler M, Yepuru M, Chaum E, Dalton JT, Eswaraka J. 17-beta estradiol protects ARPE-19 cells from oxidative stress through estrogen receptor-beta. Invest Ophthalmol Vis Sci 2010;51:5278–5287
   Google Scholar
• Dasari B, Prasanthi JR, Meiers C, Singh BB, Ghribi O. Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells. Curr Eye Res 2013;38:1159–1171
   Web of Science ®Google Scholar
• Cascio C, Russo D, Drago G, Galizzi G, Passantino R, Guarneri R, Guarneri P. 17beta-estradiol synthesis in the adult male rat retina. Exp Eye Res 2007;85:166–172
   PubMed Web of Science ®Google Scholar
• Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE, et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005;14:1991–2002
   PubMed Web of Science ®Google Scholar
• Blasiak J, Glowacki S, Kauppinen A, Kaarniranta K. Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. Int J Mol Sci 2013;14:2996–3010
   PubMed Web of Science ®Google Scholar